Order Article Reprints

Achtnichts L, Ovchinnikov A, Jakopp B, Oberle M, Nedeltchev K, Fux CA, Sellner J, Findling O. SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot. Vaccines. 2022; 10(2):341. https://doi.org/10.3390/vaccines10020341

Achtnichts, Lutz, Arkady Ovchinnikov, Barbara Jakopp, Michael Oberle, Krassen Nedeltchev, Christoph Andreas Fux, Johann Sellner, and Oliver Findling. 2022. "SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot" Vaccines 10, no. 2: 341. https://doi.org/10.3390/vaccines10020341

Achtnichts, L., Ovchinnikov, A., Jakopp, B., Oberle, M., Nedeltchev, K., Fux, C. A., Sellner, J., & Findling, O. (2022). SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot. Vaccines, 10(2), 341. https://doi.org/10.3390/vaccines10020341